Wugen
ID: 7648560Wugen is an off-the-shelf Cell Therapies for Cancer founded by Matthew Cooper, Todd Fehniger, Melissa Berrien-Elliott and John DiPersio.
1
Funding Rounds
$172.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| To** Fe****** | - | - | - |
| Ma***** Co**** |
|
- | |
| Jo** Di****** | - | - | - |
| Me***** Be************* | - | - | - |
Funding series
Funding Series Analysis
The company Wugen has raised a total of $172m in funding over 1 rounds.
Key Insights:
- Wugen Series B round, July 2021: $172m
Industries
Wugen is active in the following industries: